Cwm, LLC Ngm Biopharmaceuticals Inc Transaction History

Cwm, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	SELL	$1.17 - $1.92 $747 - $1,226	-639 Reduced 99.07%	6 $0
Q3 2023 Oct 11, 2023	SELL	$1.05 - $3.37 $1,545 - $4,960	-1,472 Reduced 69.53%	645 $1,000
Q2 2023 Aug 03, 2023	BUY	$2.44 - $4.53 $2,059 - $3,823	844 Added 66.3%	2,117 $5,000
Q1 2023 Apr 28, 2023	SELL	$3.72 - $5.4 $1,476 - $2,143	-397 Reduced 23.77%	1,273 $5,000
Q4 2022 Feb 01, 2023	BUY	$3.41 - $12.93 $5,067 - $19,213	1,486 Added 807.61%	1,670 $8,000
Q3 2022 Oct 27, 2022	BUY	$12.59 - $17.67 $2,316 - $3,251	184 New	184 $2,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.